$35.03
-0.78-2.18%
最終更新: Oct 13, 12:24 PM
$35.95
0.140.39%
Benzinga
Benzinga
Benzinga
火曜日, 10 13
Benzinga
© 2026 Benzinga | All Rights Reserved
Xenon Pharmaceuticals (XENE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.16 | $-1.19 | $-1.20 | $-1.16 |
| Actual | $-1.11 | $-1.17 | $-1.31 | $-1.15 |
| Surprise | +4.31% | +1.68% | -9.17% | +0.86% |
| Revenue | ||||
| Estimate | $937500 | $3.8M | — | — |
| Actual | $0 | $0 | — | $0 |
| Surprise | -100.0% | -100.0% | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-1.15 | $-1.17 | $-1.24 | $-1.25 |
| Revenue | ||||
| Consensus | — | $840930 | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-1.11 | $-1.16 | 4.31 % |
| Q1 | May 7, 2026 | $-1.17 | $-1.19 | 1.68 % |
| Q4 | Feb 26, 2026 | $-1.31 | $-1.20 | -9.17 % |
| Q3 | Nov 3, 2025 | $-1.15 | $-1.16 | 0.86 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0 | $937.50K | -100.0 % |
| Q1 | May 7, 2026 | $0 | $3.80M | -100.0 % |
| Q1 | May 12, 2025 | $7.50M | $1.91M | 292.7 % |
| Q4 | Feb 27, 2025 | $0 | $312.50K | -100.0 % |